Works matching IS 13960296 AND DT 2022 AND VI 35 AND IP 12
Results: 98
Correction to "Adjuvant PD‐1 inhibitor versus high‐dose interferon α‐2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis".
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15975
- Publication type:
- Article
Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15974
- By:
- Publication type:
- Article
A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15973
- By:
- Publication type:
- Article
Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5‐fluorouracil and salicylic acid.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15972
- By:
- Publication type:
- Article
More than a genital psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15971
- By:
- Publication type:
- Article
Comparison of 1064 nm Q‐switched Nd:YAG laser and Jessner peeling in melasma treatment.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15970
- By:
- Publication type:
- Article
Simvastatin and non‐segmental vitiligo: A new potential treatment option?
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15969
- By:
- Publication type:
- Article
Efficacy and safety of date palm leaf‐based ointment for treatment of cutaneous warts: A pilot clinical trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15968
- By:
- Publication type:
- Article
Cutaneous lupus erythematosus variants responsive to Janus kinase inhibition.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15967
- By:
- Publication type:
- Article
Melanoma surgery—An update.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15966
- By:
- Publication type:
- Article
Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease—A hybrid trial using a smartphone application, optical coherence tomography, and patient‐reported outcome measures
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15965
- By:
- Publication type:
- Article
High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15964
- By:
- Publication type:
- Article
A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15963
- By:
- Publication type:
- Article
Bullous pilomatricoma arising at a COVID‐19 vaccination site.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15962
- By:
- Publication type:
- Article
Is cysteamine use effective in the treatment of melasma? A systematic review and meta‐analysis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15961
- By:
- Publication type:
- Article
A case of atopic dermatitis‐associated dupilumab‐resistant alopecia totalis successfully treated with baricitinib.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15953
- By:
- Publication type:
- Article
Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15952
- By:
- Publication type:
- Article
Sharpen your sight: Trombiculosis under the dermatoscope with LC‐OCT new insights.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15951
- By:
- Publication type:
- Article
Variation of body regional responses to Ustekinumab and Secukinumab in psoriasis patients: A real‐world retrospective study and literature review.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15950
- By:
- Publication type:
- Article
Influence of serum vitamin D level in the response of actinic keratosis to ingenol mebutate.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15949
- By:
- Publication type:
- Article
Juvenile dermatomyositis‐associated calcinosis successfully treated with combined immunosuppressive, bisphosphonate, oral baricitinib and physical therapy.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15960
- By:
- Publication type:
- Article
Proton pump inhibitor‐induced subacute cutaneous lupus erythematosus.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15959
- By:
- Publication type:
- Article
Real‐world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15958
- By:
- Publication type:
- Article
Benvitimod for the treatment of psoriasis: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15957
- By:
- Publication type:
- Article
Long lasting response to anti‐tumor necrosis factor α agents in psoriasis: A real life experience.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15956
- By:
- Publication type:
- Article
Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real‐world experience.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15955
- By:
- Publication type:
- Article
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15954
- By:
- Publication type:
- Article
Intravenous immunoglobulin for pembrolizumab‐induced bullous pemphigoid‐like eruption: A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15948
- By:
- Publication type:
- Article
Intravenous immunoglobulin therapy in children with severe atopic dermatitis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15947
- By:
- Publication type:
- Article
Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15946
- By:
- Publication type:
- Article
Successful treatment with ustekinumab in CARD14‐associated papulosquamous eruption in a Brazilian child.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15939
- By:
- Publication type:
- Article
Fatal low‐dose methotrexate toxicity: A case report and literature review.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15945
- By:
- Publication type:
- Article
Step by step surgery for hidradenitis suppurativa.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15938
- By:
- Publication type:
- Article
Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15942
- By:
- Publication type:
- Article
Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real‐life study.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15941
- By:
- Publication type:
- Article
Alopecia areata induced by Adalimumab in a patient with Crohn's disease.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15940
- By:
- Publication type:
- Article
Leucocytoclastic vasculitis‐like reaction induced by tocilizumab in a patient with rheumatoid arthritis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15944
- By:
- Publication type:
- Article
Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15943
- By:
- Publication type:
- Article
New onset of palmoplantar keratosis triggered by COVID‐19 vaccination.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15937
- By:
- Publication type:
- Article
Local hyperthermia as a good treatment option for hands and feet warts in children: Case series report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15936
- By:
- Publication type:
- Article
Intralesional combined furosemide and digoxin in cutaneous warts treatment: A randomized controlled clinical trial.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15935
- By:
- Publication type:
- Article
Update of pathophysiology and treatment options of seborrheic keratosis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15934
- By:
- Publication type:
- Article
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15933
- By:
- Publication type:
- Article
Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15932
- By:
- Publication type:
- Article
Tapinarof for the treatment of psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15931
- By:
- Publication type:
- Article
Treatment of atopic dermatitis using topical antifungal drugs: A meta‐analysis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15930
- By:
- Publication type:
- Article
Dupilumab: Advances in the off‐label usage of IL4/IL13 antagonist in dermatoses.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15924
- By:
- Publication type:
- Article
Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta‐analysis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15928
- By:
- Publication type:
- Article
COVID‐19 vaccine‐related eruption of papules and plaques—A case report.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15927
- By:
- Publication type:
- Article
Treatment of acquired reactive perforating collagenosis with dupilumab in a patient with end‐stage renal disease.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 12, p. 1, doi. 10.1111/dth.15926
- By:
- Publication type:
- Article